These data indicate that future studies in these areas, as well as therapeutics targeting dopamine-mediated immune activity, should carefully evaluate not only which dopamine receptors/transporters are involved but also which cell type(s) are being affected by signaling through those receptors
These stimulants directly target the dopaminergic system and are the current first-line pharmacological treatments for ADHD, in addition to nonstimulants (atomoxetine, guanfacine, and clonidine) that also modify dopamine levels (Murai et al., 1998
Glutathione is intended strictly for research use only
Cycling protocols further reduce accumulation concerns by providing regular breaks
This study was supported by FAR2024PD (#E93C24000570005) to FB and by PRD2026 from the Department of Life Sciences, University of Modena and Reggio Emilia, Italy (FB)
Large serving size